Arphra
live
S&P 5000.34+0.35%
NASDAQ0.000.00%
DOW50,872.11+2.56%
VIX20.95+16.00%
US10Y4.53+1.21%
EUR/USD1.1604+0.24%
GOLD4,303.8+1.45%
WTI81.11-5.50%
BTC65,514.43+3.44%
S&P 5000.34+0.35%
NASDAQ0.000.00%
DOW50,872.11+2.56%
VIX20.95+16.00%
US10Y4.53+1.21%
EUR/USD1.1604+0.24%
GOLD4,303.8+1.45%
WTI81.11-5.50%
BTC65,514.43+3.44%

ALMR

Alamar Biosciences, Inc.
HealthcareBiotechnologyUSUSDPeers →
$22.00
LiveJun 12, 2026
AI Brief
Market cap
$206.25M
52w range
18.85 – 27.20
P / E
EPS
Volume
246.8K
Revenue · FY

Explain this page

Arphra AI
Business description
· company · SEC profile

Alamar Biosciences, Inc.

Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.

Founded
IPO
Apr 17, 2026
Employees
222
HQ
Fremont, CA
CEO
Justin J. McAnear
CFO
Exchange
NASDAQ
Fiscal year
Identifiers
· company_identifiers
CIK0002104204
CUSIP010911105
ISINUS0109111056
FIGIALMR US
LEI